Dotmed -- Advanced imaging modalities and new chemotherapy drugs are driving down cancer deaths, according to a new study, buttressing arguments that expensive advanced imaging is worth its cost.
Dotmed -- Advanced imaging modalities and new chemotherapy drugs are driving down cancer deaths, according to a new study, buttressing arguments that expensive advanced imaging is worth its cost.
